Related Articles
MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
Plasma exosomal microRNA‑125b as a monitoring biomarker of resistance to mFOLFOX6‑based chemotherapy in advanced and recurrent colorectal cancer patients
miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling
MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is downregulated in human osteosarcoma
The diagnostic and prognostic value of plasma microRNA‑125b‑5p in patients with multiple myeloma